Vanberra Signal

BigHat

Curated by Signal

Provider of antibody therapies developed by machine learning and synthetic biology

Overview

Provider of antibody therapies developed by machine learning and synthetic biology. The company offers an AI-enabled antibody design platform named Milliner, that offers antibody therapies to treat intractable conditions like chronic illnesses to life-threatening diseases.

Key facts

Founded
2019

Business model

Contact

Open roles

23 roles
  • Director of Machine Learning

    San Mateo, CA · On-site · Volunteer

  • Senior Director, Controller

    San Mateo, CA · On-site · Volunteer

  • Senior Director, Clinical Operations

    San Mateo, CA · On-site · Volunteer

+ 20 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Providing analytics platform for genome analysis.

    Life Sciences TechnologyCambridge, United States
  • NextBio provides a platform to aggregate and interpret large quantities of genomic data for research and clinical applications.

    Life Sciences TechnologySanta Clara, United States
  • Developer of progesterone based fertility test kits

    Life Sciences TechnologyBoulder, United States

About BigHat

What does BigHat do?

Provider of antibody therapies developed by machine learning and synthetic biology.

Where is BigHat headquartered?

BigHat is headquartered in San Carlos, United States.

When was BigHat founded?

BigHat was founded in 2019.

Which sector is BigHat in?

BigHat operates in Life Sciences Technology.

Who are BigHat's competitors?

Companies similar to BigHat include NextCode Health, NextBio, and Proov.

Is BigHat hiring?

Yes. BigHat has 23 open roles listed on Vanberra Signal.